Teva to raise $34bn in new equity and debt for Allergan bid

© 2025 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 4 Bouverie Street, London, EC4Y 8AX. Part of the Delinian group. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions

Cookies Settings
Syndicated Loans
Investment Grade Loans

Teva to raise $34bn in new equity and debt for Allergan bid

Elly Whittaker
July 27, 2015 03:15 pm
teva-for-web.jpg

Israeli pharmaceutical company Teva has 15 days to raise $33.75bn of funds to buy US firm Allergan's generics business.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login

Topics

Syndicated LoansNews contentIsraelEmerging Market LoansUnited StatesInvestment Grade LoansEmerging MarketsBarclaysMiddle East LoansEM Middle East
EW
Elly Whittaker
Gift this article